Key Takeaways DXCM enters Q3 with solid momentum from patient growth, access gains, and global expansion.G7 penetration and early Stelo adoption are fueling stronger commercial and channel performance for DXCM.DXCM expects margin gains as freight costs ease and inventory stabilization efforts take hold.DexCom, Inc. (DXCM) is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported quarter, the company’s adjusted earnings per share (EPS) of 48 centssurpassed the ...